fda semaglutide compounding enforcement october 2025 GLP-1 Medications – Guidance and Compounded Products Compounded weight-loss and hormone drugs

chloramphenicol), and concurrent iron or folic acid deficiency

Ongoing Follow-Up and Treatment Adjustment GLP-1 weight loss treatment is not a one-time intervention

With professional evaluation, customized dosing, and continuous monitoring, GLP-1 therapy offers a safe and structured path to lasting results

Zepbound is a registered trademark of Eli Lilly

"Hair loss was reported more frequently in patients with greater weight loss (20%), suggesting that the events of hair loss were potentially related to the magnitude of weight loss." "Patient safety is of utmost importance to Novo Nordisk," the statement continued

Chang KC, Shao SC, Kuo S, Yang CY, Chen HY, Chan YY, et al